Profound Medical PROF US — Depreciation
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Profound Medical in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Profound Medical's us — depreciation.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Profound Medical's US — depreciation?
- Profound Medical (PROF) reported US — depreciation of $66K in Q1 2026.
- How has Profound Medical's US — depreciation changed year-over-year?
- Profound Medical's US — depreciation decreased by 35.9% year-over-year, from $103K to $66K.
- What is the long-term trend for Profound Medical's US — depreciation?
- Over 2 years (2023 to 2025), Profound Medical's US — depreciation has grown at a -30.7% compound annual growth rate (CAGR), from $670K to $322K.
- What does US — depreciation mean?
- Represents the systematic allocation of the cost of tangible assets over their useful lives specifically for the United States segment. Monitoring this expense helps investors understand the capital expenditure cycle and the aging profile of the company's domestic asset base.